Ring therapeutics

Biotechnology company based in Cambridge, Massachusetts, focusing on the development of Anellovector™ therapeutics. The company is pioneering a redosable and targetable gene therapy platform by leveraging the human commensal virome, aiming to expand gene therapy applications beyond gene replacement. Ring Therapeutics primarily targets patients with previously inaccessible diseases, offering new treatment modalities and mechanisms.

Ring therapeutics was discovered on July 31st 2021 and it currently has a search volume of 720 with a growth of +4900%.